Clinical Trials Logo

Uterine Hemorrhage clinical trials

View clinical trials related to Uterine Hemorrhage.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06398145 Not yet recruiting - Clinical trials for Abnormal Uterine Bleeding

D-chiro-inositol and AUB

Start date: June 1, 2024
Phase: Phase 2
Study type: Interventional

Patients with AUB will undergo 6-month treatment with D-chiro-inositol and will fill in questionnaires on AUB, with the evaluation of hormonal serum levels.

NCT ID: NCT06219538 Not yet recruiting - Clinical trials for Cesarean Section Complications

DAISY Uterine Drain Device Evaluation

Start date: May 2024
Phase: N/A
Study type: Interventional

The goal of this study is to obtain user feedback while placing and observing the DAISY uterine drain with wall suction. This study defines the obstetrical surgeons as "users" and the patients in whom the drain is placed as "participants." Participants are pregnant women who are undergoing cesarean delivery (CD), who have not entered active labor, who have consented to drain placement and who have met all the inclusion/exclusion criteria. Users are staff or fellow obstetrical surgeons who will use the drain and provide the evaluation.

NCT ID: NCT06201767 Not yet recruiting - Clinical trials for Abnormal Uterine Bleeding

Evaluation of Abnormal Uterine Bleeding in Adolescents: A Cross Sectional Observational Study

Start date: January 2024
Phase:
Study type: Observational

Evaluation of Abnormal Uterine Bleeding in Adolescents: A Cross Sectional Observational Study

NCT ID: NCT06050161 Not yet recruiting - Clinical trials for Pelvic Organ Prolapse

Evaluating Artisential Laparoscopic Instruments in Gynecologic Surgery

MIGS-ART
Start date: September 20, 2023
Phase: N/A
Study type: Interventional

This study evaluates the efficacy and safety of Artisential laparoscopic instruments in minimally invasive gynecologic surgery.

NCT ID: NCT06004908 Not yet recruiting - Clinical trials for Postmenopausal Bleeding

Role of MRI in Diagnosis of Postmenopausal Bleeding Causes

Start date: October 1, 2023
Phase:
Study type: Observational

The aim of the study is to determine the diagnostic performance of MRI of endometrial pathology in postmenopausal women with postmenopausal bleeding

NCT ID: NCT05996926 Not yet recruiting - Clinical trials for Cesarean Section Complications

Diagnostic Accuracy of Saline Sonohystrography vs. 3D Transvaginal Ultrasound for Cesarean Scar Defect Assessment

Start date: August 30, 2023
Phase: N/A
Study type: Interventional

To compare accuracy of three dimensional transvaginal ultrasound versus the "gold standard" saline infused sonography for assessing the characteristics, frequency and appearance of caesarean scar defects in symptomatic patients with a history of cesarean section.

NCT ID: NCT05645848 Not yet recruiting - Placenta Previa Clinical Trials

The Rate and Predictors of Vaginal Bleeding Among Women With Placenta Previa

Start date: December 2022
Phase:
Study type: Observational

Placenta previa is usually diagnosed when the placenta implanted in the lower uterine segment, thus partially or totally overlying the internal os . It occurs with an incidence of 0.3-0.5%. It is associated mainly with prior caesarean delivery . The condition is frequently complicated by invasion of placental villi beyond the decidua basalis causing placenta accreta . Placenta previa is a major cause of massive haemorrhage during pregnancy and after delivery . The antepartum bleeding from placenta previa- can be life-threatening, thus, the prediction of this bleeding is of great importance . It is important to distinguish between women at high and low risk for antepartum haemorrhage with placenta previa especially at late pregnancy . However, the potential risk factors for antepartum haemorrhage in women with placenta previa have not been thoroughly examined.

NCT ID: NCT05224726 Not yet recruiting - Clinical trials for Cesarean Section Complications

Platelet Rich Plasma for Uterine Scar

AA-PRP
Start date: December 2023
Phase: N/A
Study type: Interventional

When vessel wall injury occurs, platelets become activated, releasing more than 30 bioactive proteins, many of which have a fundamental role in hemostasis, inflammation and ultimate wound healing. Platelet-rich plasma (PRP), a modification of fibrin glue made from autologous blood, is being used to deliver growth factors in high concentration to sites requiring wound healing. PRP is obtained from a sample of patients' blood drawn at the time of treatment. As the rate of cesarean deliveries has been rising, long-term adverse sequelae due to uterine scar defects have been increasing. PRP might be a simple preventive treatment that potentially can reduce morbidity following cesarean deliveries.

NCT ID: NCT04915196 Not yet recruiting - Clinical trials for Iron Deficiency Anemia

Tolerability of Iron Therapy in Women With AUB

Start date: July 1, 2021
Phase:
Study type: Observational

Telephone surveys of female patients using liposomally-bound iron and traditional iron sulphate preparations for the management of iron deficiency anemia to determine gastrointestinal tolerability.

NCT ID: NCT04579965 Not yet recruiting - Clinical trials for Dysfunctional Uterine Bleeding

Misotac vs Combined Oral Contraceptive Pill in the Treatment of Symptomatic Isthmocele

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Isthmocele is a growing concern as a cause of abnormal uterine bleeding, especially post menstrual bleeding which may be present in up to 82% of these cases (Iannone et al 2019). our trial is a randomized clinical trial in which women will be randomly allocated to either medical treatment by oral contraceptive or to medical treatment by misotac.